Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.

Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814

NCT00403585 ·Status: COMPLETED ·Phase: PHASE4

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

NCT00531167 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

NCT00307489 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

NCT00116805 ·Status: COMPLETED ·Phase: PHASE3

Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

NCT00316719 ·Status: COMPLETED ·Phase: PHASE3

Suboptimal Responders to Adefovir Switching to Entecavir

NCT00718887 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

NCT00042393 ·Status: APPROVED_FOR_MARKETING

Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B

NCT00071201 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

NCT00537537 ·Status: COMPLETED ·Phase: PHASE4

A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection

NCT00605384 ·Status: TERMINATED ·Phase: PHASE3

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

NCT00347009 ·Status: COMPLETED ·Phase: PHASE4

EFFORT Further Extension Study

NCT02826070 ·Status: UNKNOWN ·Phase: PHASE4

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

NCT01353742 ·Status: COMPLETED ·Phase: PHASE1

Lamivudine and Adefovir to Treat Chronic Hepatitis B

NCT00023309 ·Status: COMPLETED ·Phase: PHASE2

Entecavir Plus Adefovir in Lamivudine-Resistant Patients

NCT00986778 ·Status: WITHDRAWN ·Phase: PHASE4

Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B

NCT00606099 ·Status: WITHDRAWN ·Phase: PHASE4

Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B

NCT00324961 ·Status: COMPLETED ·Phase: PHASE4

Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients

NCT00441974 ·Status: COMPLETED ·Phase: PHASE4

HBV Reactivation in Anti CD20 Treatment

NCT05768061 ·Status: UNKNOWN

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

NCT00023153 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4

An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)

NCT01205165 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

NCT00117676 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma

NCT00455091 ·Status: TERMINATED

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine

NCT00640588 ·Status: COMPLETED ·Phase: PHASE3